These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21115777)

  • 21. Diabetes News.
    Regier EE; Gao HX; Close KL
    J Diabetes; 2015 Nov; 7(6):749-53. PubMed ID: 26223410
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of glycemic control and variability in patients with type 2 and posttransplantation diabetes mellitus.
    Werzowa J; Pacini G; Hecking M; Fidler C; Haidinger M; Brath H; Thomas A; Säemann MD; Tura A
    J Diabetes Complications; 2015; 29(8):1211-6. PubMed ID: 26264400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Intensive Glycemic Control on Clinical Outcomes Among Patients With Type 2 Diabetes With Different Levels of Cardiovascular Risk and Hemoglobin A
    Tian J; Ohkuma T; Cooper M; Harrap S; Mancia G; Poulter N; Wang JG; Zoungas S; Woodward M; Chalmers J
    Diabetes Care; 2020 Jun; 43(6):1293-1299. PubMed ID: 32193249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intensive glucose control and cardiovascular outcomes in type 2 diabetes.
    Macisaac RJ; Jerums G
    Heart Lung Circ; 2011 Oct; 20(10):647-54. PubMed ID: 20807681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycemic control and cardiovascular disease: what's a doctor to do?
    Kishore P; Kim SH; Crandall JP
    Curr Diab Rep; 2012 Jun; 12(3):255-64. PubMed ID: 22467273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of Purified Anthocyanins in Improving Cardiometabolic Risk Factors in Chinese Men and Women with Prediabetes or Early Untreated Diabetes-A Randomized Controlled Trial.
    Yang L; Ling W; Yang Y; Chen Y; Tian Z; Du Z; Chen J; Xie Y; Liu Z; Yang L
    Nutrients; 2017 Oct; 9(10):. PubMed ID: 28994705
    [No Abstract]   [Full Text] [Related]  

  • 27. [Questions for practicing internists].
    Zinnenlauf S
    Praxis (Bern 1994); 2008 Aug; 97(17):945-6. PubMed ID: 18777778
    [No Abstract]   [Full Text] [Related]  

  • 28. Replacing Insulin Glargine with Neutral Protamine Hagedorn (NPH) Insulin in a Subpopulation of Study Subjects in the Action to Control Cardiovascular Risk in Diabetes (ACCORD): Effects on Blood Glucose Levels, Hypoglycemia and Patient Satisfaction.
    Berard L; Cameron B; Woo V; Stewart J
    Can J Diabetes; 2015 Aug; 39(4):296-301. PubMed ID: 25819531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycemic control and cardiovascular mortality.
    Riddle MC
    Curr Opin Endocrinol Diabetes Obes; 2011 Apr; 18(2):104-9. PubMed ID: 21522000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Four decades of uncertainty: landmark trials in glycaemic control and cardiovascular outcome in type 2 diabetes.
    Matthews DR; Tsapas A
    Diab Vasc Dis Res; 2008 Sep; 5(3):216-8. PubMed ID: 18777497
    [No Abstract]   [Full Text] [Related]  

  • 31. Decrease mortality in type II diabetes mellitus: glycemic and renal function control.
    Borghi C; Ventura F
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e13-e15. PubMed ID: 29538138
    [No Abstract]   [Full Text] [Related]  

  • 32. [Glycemic targets and cardiovascular morbi-mortality].
    Bordier L; Bauduceau B
    Presse Med; 2013 May; 42(5):855-60. PubMed ID: 23286961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategies for optimizing glycemic control and cardiovascular prognosis in patients with type 2 diabetes mellitus.
    O'Keefe JH; Abuannadi M; Lavie CJ; Bell DS
    Mayo Clin Proc; 2011 Feb; 86(2):128-38. PubMed ID: 21270290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is glycemic control a quinidine-like intervention?
    Bloomgarden ZT
    J Diabetes; 2014 Sep; 6(5):387-8. PubMed ID: 24842383
    [No Abstract]   [Full Text] [Related]  

  • 35. [Intensive blood sugar treatment in type 2 diabetics: no evidence for increased mortality in the ADVANCE study compared with ACCORD study].
    Füchtenbusch M; Hummel M
    MMW Fortschr Med; 2008 Apr; 150(17):42-4. PubMed ID: 18510157
    [No Abstract]   [Full Text] [Related]  

  • 36. Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High-Risk Vascular Disease Treated With Statin Therapy.
    Menon V; Kumar A; Patel DR; John JS; Wolski KE; McErlean E; Riesmeyer JS; Weerakkody G; Ruotolo G; Cremer PC; Nicholls SJ; Lincoff AM; Nissen SE
    J Am Heart Assoc; 2020 Jan; 9(1):e014328. PubMed ID: 31852422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comment from the diabetology viewpoint].
    Stahl M
    Praxis (Bern 1994); 2008 Aug; 97(17):943-4. PubMed ID: 18777777
    [No Abstract]   [Full Text] [Related]  

  • 38. Diabetes. Insights from the extended follow-up of the ACCORD trial.
    Zoungas S; Woodward M
    Nat Rev Cardiol; 2011 Jun; 8(6):308-10. PubMed ID: 21502962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Daily glycaemic variability: benefits of optimal control.
    Cavalot F
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():1-2. PubMed ID: 24034512
    [No Abstract]   [Full Text] [Related]  

  • 40. Glucose lowering and cardiovascular disease: what do we know and what should we do?
    Cheng AY; Leiter LA
    Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S25-31. PubMed ID: 20489417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.